Medication-Induced Oral Hyperpigmentation: A Systematic Review

References

• WHO. International drug monitoring: the role of national centres. Rep WHO Meet. 1972;1–25.
   Google Scholar
• Yuan A, Woo S-B. Adverse drug events in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(1):35–47. doi:10.1016/j.oooo.2014.09.009
   PubMed Web of Science ®Google Scholar
• Abdollahi M, Radfar M. A review of drug-induced oral reactions. J Contemp Dent Pract. 2003;4(1):10–31. doi:10.5005/jcdp-4-1-10
   PubMedGoogle Scholar
• Meyerson MA, Cohen PR, Hymes SR. Lingual hyperpigmentation associated with minocycline therapy. Oral Surg Oral Med Oral Pathol Oral Radiol. 1995;79(2):180–184. doi:10.1016/S1079-2104(05)80279-3
   Web of Science ®Google Scholar
• Ficarra G, Shillitoe EJ, Adler-Storthz K, et al. Oral melanotic macules in patients infected with human immunodeficiency virus. Oral Surg Oral Med Oral Pathol. 1990;70(6):748–755. doi:10.1016/0030-4220(90)90014-J
   Google Scholar
• Eisen D. Disorders of pigmentation in the oral cavity. Clin Dermatol. 2000;18(5):579–587. doi:10.1016/S0738-081X(00)00148-6
   Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–e34. doi:10.1016/j.jclinepi.2009.06.006
   PubMed Web of Science ®Google Scholar
• Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Vol. 5. 2008. doi:10.1002/9780470712184
   Google Scholar
• Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23(2):60–63. doi:10.1136/bmjebm-2017-110853
   PubMedGoogle Scholar
• Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality if Nonrandomized Studies in Meta-Analyses. 2016.
   Google Scholar
• Kumar B, Saraswat A, Kaur I. Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients. Clin Exp Dermatol. 2002;27(1):8–13. doi:10.1046/j.0307-6938.2001.00947.x
   Web of Science ®Google Scholar
• Fendrich P, Brooke RI. An unusual case of oral pigmentation. Oral Surg Oral Med Oral Pathol. 1984;58(3):288–289. doi:10.1016/0030-4220(84)90056-2
   Google Scholar
• Johnston S. Feeling blue? Minocycline-induced staining of the teeth, oral mucosa, sclerae and ears - A case report. Br Dent J. 2013;215(2):71–73. doi:10.1038/sj.bdj.2013.682
   Web of Science ®Google Scholar
• Erbagci Z. Amlodipine associated hyperpigmentation. Saudi Med J. 2004;25(1):103–105.
   Web of Science ®Google Scholar
• Treister NS, Magalnick D, Bin WS. Oral mucosal pigmentation secondary to minocycline therapy: report of two cases and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(6):718–725. doi:10.1016/j.tripleo.2003.11.006
   Web of Science ®Google Scholar
• Vasudevan B. An unusual case of capecitabine hyperpigmentation: is hyperpigmentation a part of hand-foot syndrome or a separate entity. Indian J Pharmacol. 2010;42(5):326–328. doi:10.4103/0253-7613.70401
   Web of Science ®Google Scholar
• Siller GM, Tod MA, Savage NW. Minocycline-induced oral pigmentation. J Am Acad Dermatol. 1994;30(2):350–354. doi:10.1016/S0190-9622(94)70038-9
   Web of Science ®Google Scholar
• Tosios KI, Kalogirou EM, Sklavounou A. Drug-associated hyperpigmentation of the oral mucosa: report of four cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(3):e54–e66. doi:10.1016/j.oooo.2017.10.006
   Web of Science ®Google Scholar
• Salman RA, Salman DG, Glickman RS. Minocycline induced pigmentation of the oral cavity. J Oral Med. 1985;40(3):154–157.
   Google Scholar
• Renald Perusse RM. Oral Pigmentation induced by premarin. Laval Univ Sch Dent. 1991;48:61–64.
   Google Scholar
• Lyne A, Creedon A, Bailey BMW. Mucosal pigmentation of the hard palate in a patient taking imatinib. BMJ Case Rep. 2015;2015(apr16 1):1–3. doi:10.1136/bcr-2015-209335
   Google Scholar
• Romeo U, Palaia G, Fantozzi PJ, Tenore G, Bosco D, Rare A. Case of melanosis of the hard palate mucosa in a patient with chronic myeloid leukemia. Case Rep Dent. 2015;2015:9–12. doi:10.1155/2015/817094
   Google Scholar
• Patel K, Cheshire D, Vance A. Oral and systemic effects of prolonged minocycline therapy. Br Dent J. 1998;185(185):560. doi:10.1038/sj.bdj.4809867
   Web of Science ®Google Scholar
• Resende RG, Teixeira RGL, Vasconcelos FDO, Silva MEDS, Abreu MHG, Gomez RS. Imatinib-associated hyperpigmentation of the palate in post-HSCT patient. J Craniomaxillofac Surg. 2012;40(5):e140–e143. doi:10.1016/j.jcms.2011.07.010
   Web of Science ®Google Scholar
• Parvaei P, Mortazavi H, Baharvand M. Severe pigmentation of oral mucosa, skin and nails due to breast cancer chemotherapy – case report. Dent Med Probl. 2015;52(3):363–365.
   Google Scholar
• Nestor LA, Flint S, Galvin S. Unusual case of hyperpigmentation secondary to irinotecan. BMJ Case Rep. 2016;2016:1–2. doi:10.1136/bcr-2016-217545
   Google Scholar
• Odell EW, Hodgson RP, Haskell R. Oral presentation of minocycline-induced black bone disease. Oral Surg Oral Med Oral Pathol Oral Radiol. 1995;79(4):459–461. doi:10.1016/S1079-2104(05)80128-3
   Web of Science ®Google Scholar
• Ozog DM, Gogstetter DS, Scott G, Gaspari AA. Minocycline-induced hyperpigmentation in patients with pemphigus and pemphigoid. Arch Dermatol. 2000;136(9):1133–1138. doi:10.1001/archderm.136.9.1133
   Google Scholar
• Cale AE, Freedman PD, Lumerman H. Pigmentation of the jawbones and teeth secondary to minocycline hydrochloride therapy. J Periodontol. 1988;59(2):112–114. doi:10.1902/jop.1988.59.2.112
   Web of Science ®Google Scholar
• Morrow GL, Abbott RL. Minocycline-induced scleral, dental, and dermal pigmentation. Am J Ophthalmol. 1998;125(3):396–397. doi:10.1016/S0002-9394(99)80156-1
   Web of Science ®Google Scholar
• de Filho MRM, da Silva CAD, da Dourado MR, de Pires MBO, Pêgo SPB, de Freitas EM. Palate hyperpigmentation caused by prolonged use of the anti-malarial chloroquine. Head Neck Pathol. 2012;6(1):48–50. doi:10.1007/s12105-011-0288-5
   Google Scholar
• Levy H. Chloroquine-induced pIgmentatIon. S Afr Med J. 1982;62(December1981):1981–1983.
   Google Scholar
• De Andrade BAB, Fonseca FP, Pires FR, et al. Hard palate hyperpigmentation secondary to chronic chloroquine therapy: report of five cases. J Cutan Pathol. 2013;40(9):833–838. doi:10.1111/cup.12182
   Web of Science ®Google Scholar
• Beehner ME, Houston GD, Young JD. Oral pigmentation secondary to minocycline therapy. J Oral Maxillofac Surg. 1986;44(7):582–584. doi:10.1016/S0278-2391(86)80104-5
   Web of Science ®Google Scholar
• Birek C, Ph D. Short communications & case reports associated two cases of oral pigmentation with quinidine therapy. Oral Surg Oral Med Oral Pathol. 1988;66(66):59–61. doi:10.1016/0030-4220(88)90067-9
   Google Scholar
• Bombeccari GP, Garagiola U, Pallotti F, et al. Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib. Maxillofac Plast Reconstr Surg. 2017;39(1). doi:10.1186/s40902-017-0136-y
   Google Scholar
• Buddula A. Staining of palatal torus secondary to long term minocycline therapy. J Indian Soc Periodontol. 2009;13(1):48. doi:10.4103/0972-124x.51896
   Google Scholar
• Balaji G, Maharani B, Ravichandran V, Parthasarathi T. Linezolid induced black hairy tongue. Indian J Pharmacol. 2014;46(6):653–655. doi:10.4103/0253-7613.144942
   Web of Science ®Google Scholar
• Bahloul E, Jallouli M, Garbaa S, et al. Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases. Lupus. 2017;26(12):1304–1308. doi:10.1177/0961203317700486
   Web of Science ®Google Scholar
• Acharya S, Pai KM, Bhat S, Mamatha B, Bejadi V, Acharya S. Oral changes in patients undergoing chemotherapy for breast cancer. Indian J Dent Res. 2017;28(3):261–268. doi:10.4103/ijdr.IJDR_379_16
   Google Scholar
• Mahler R, Sissons W, Watters K. Pigmentation induced by quinidine therapy. Arch Dermatol. 1986;122(9):1062–1064. doi:10.1001/archderm.1986.01660210112031
   Google Scholar
• Watson IB, MacDonald DG. Amodioquine induced oral pigmentation ‐ a light and electron microscopic study. J Oral Pathol Med. 1974;3(1):16–21. doi:10.1111/j.1600-0714.1974.tb01694.x
   Web of Science ®Google Scholar
• Co ML, Esteban MJ. Lingual hyperpigmentation after 5-fluorouracil chemotherapy. BMJ Case Rep. 2017;2017:1–2. doi:10.1136/bcr-2017-219806
   Google Scholar
• Ayangco L, Sheridan PJ. Minocycline-induced staining of torus palatinus and alveolar bone. J Periodontol. 2003;74(5):669–671. doi:10.1902/jop.2003.74.5.669
   Web of Science ®Google Scholar
• de Andrade BAB, Padron-Alvarado NA, Muñoz-Campos EM. Hyperpigmentation of hard palate induced by chloroquine therapy. J Clin Exp Dent. 2017;9(12):e1487–e1491. doi:10.4317/jced.54387
   Google Scholar
• Wong M, Sade S, Gilbert M, Klie HBE. Oral melanosis after tyrosine kinase inhibition with imatinib for chronic myelogenous leukemia: report of a case and review of the literature. Dermatol Online J. 2011;17(5).
   Google Scholar
• López-Jornet P, Pons-Fuster A. Pigmented oral mucosa due to quinacrine. N Y State Dent J. 2011;77(6):49–51.
   Google Scholar
• Mattsson U, Halbritter S, Mörner Serikoff E, Christerson L, Warfvinge G. Oral pigmentation in the hard palate associated with imatinib mesylate therapy: a report of three cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111(5):e12–e16. doi:10.1016/j.tripleo.2010.11.006
   Web of Science ®Google Scholar
• Di Tullio F, Mandel VD, Scotti R, Padalino C, Pellacani G. Imatinib-induced diffuse hyperpigmentation of the oral mucosa, the skin, and the nails in a patient affected by chronic myeloid leukemia: report of a case and review of the literature. Int J Dermatol. 2018;57(7):784–790. doi:10.1111/ijd.13931
   Web of Science ®Google Scholar
• Song HSKH, Kang HY. Imatinib mesylate-induced hyperpigmentation of the nose and palate. Ann Dermatol. 2014;26(4):532–533. doi:10.5021/ad.2014.26.4.532
   Web of Science ®Google Scholar
• Roeker LEWA, Wolanskyj AP. Imatinib-associated melanosis of the palate. Am J Hematol. 2014;89(5):564. doi:10.1002/ajh.23589
   Web of Science ®Google Scholar
• Khoo TL, Catalano A, Supple S, et al. Hyperpigmentation of the hard palate associated with imatinib therapy for chronic myeloid leukemia with a genetic variation in the proto-oncogene c-KIT. Leuk Lymphoma. 2013;54(1):186–188. doi:10.3109/10428194.2012.702904
   PubMed Web of Science ®Google Scholar
• Singh NBS, Bakhshi S. Imatinib-induced dental hyperpigmentation in childhood chronic myeloid leukemia. J Pediatr Hematol Oncol. 2007;29(3):208–209. doi:10.1097/MPH.0b013e318033a76c
   Web of Science ®Google Scholar
• Li CC, Malik SM, Blaeser BF, et al. Mucosal pigmentation caused by imatinib: report of three cases. Head Neck Pathol. 2012;6(2):290–295. doi:10.1007/s12105-011-0325-4
   Google Scholar
• Lewis DM. Diffuse pigmentation of the palate. J Okla Dent Assoc. 2009;100:24–25.
   Google Scholar
• Beacher NG, Brodie MJ, Goodall C. A case report: retigabine induced oral mucosal dyspigmentation of the hard palate. BMC Oral Health. 2015;15(1):1–5. doi:10.1186/s12903-015-0102-y
   Web of Science ®Google Scholar
• Steele JC, Triantafyllou A, Rajlawat BPFE, Field EA. Oral mucosal hyperpigmentation and horizontal melanonychia caused by imatinib. Clin Exp Dermatol. 2012;37(4):432–433. doi:10.1111/j.1365-2230.2011.04196.x
   Web of Science ®Google Scholar
• Dixon DR, Yassin A. Oral effects and early implant survival results after imatinib discontinuation therapy for chronic myelogenous leukemia: a case report. J Clin Periodontol. 2017;7(3):115–120. doi:10.1902/cap.2016.160050
   Google Scholar
• Oliveira SR, de Azevedo Branco LG, Rocha AL, et al. Association of oral mucosa hyperpigmentation with imatinib mesylate use: a cross-sectional study and a systematic literature review. Clin Oral Investig. 2019;23(12):4371–4382. doi:10.1007/s00784-019-02886-0
   Web of Science ®Google Scholar
• Chacón-Dulcey V, López-Labady J, Villarroel-Dorrego M, et al. Oral manifestations associated with antimalarial therapy in patients with systemic lupus erythematosus. Lupus. 2020;29(7):761–766. doi:10.1177/0961203320922620
   Web of Science ®Google Scholar
• Kristensson JH, Sander BB, von Euler-chelpin M, Lynge E. Predictors of non-participation in cervical screening in Denmark. Cancer Epidemiol. 2014;38(2):174–180. doi:10.1016/j.canep.2013.12.007
   Web of Science ®Google Scholar
• Mascitti M, Luconi E, Togni L, Barlattani A, Santarelli A. Imatinib-related hyperpigmentation of oral mucosa: case report and literature review. J Dent Sci. 2019;14(3):335–337. doi:10.1016/j.jds.2019.02.005
   Web of Science ®Google Scholar
• Lerman MA, Karimbux N, Guze KA, Bin WS. Pigmentation of the hard palate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(1):8–12. doi:10.1016/j.tripleo.2008.07.022
   Web of Science ®Google Scholar
• Langford A, Pohle HD, Gelderblom H, Zhang X, Reichart PA. Oral hyperpigmentation in HIV-infected patients. Oral Surg Oral Med Oral Pathol. 1989;67(3):301–307. doi:10.1016/0030-4220(89)90360-5
   Google Scholar
• LaPorta VN, Nikitakis NG, Sindler AJ, Reynolds MA. Minocycline-associated intra-oral soft-tissue pigmentation: clinicopathologic correlations and review. J Clin Periodontol. 2005;32(2):119–122. doi:10.1111/j.1600-051X.2005.00646.x
   Web of Science ®Google Scholar
• Kleinegger CL, Hammond HL, Finkelstein MW. Oral mucosal hyperpigmentation secondary to antimalarial drug therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(2):189–194. doi:10.1067/moe.2000.106340
   Web of Science ®Google Scholar
• Geria AN, Tajirian AL, Kihiczak G, Schwartz RA. Minocycline-induced skin pigmentation: an update. Acta Dermatovenerol Croat. 2009;17(2):123–126.
   PubMed Web of Science ®Google Scholar
• Dai J, Belum VR, Wu S, Sibaud V, Lacouture ME. Pigmentary changes in patients treated with targeted anticancer agents: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(5):902–910.e2. doi:10.1016/j.jaad.2017.06.044
   Web of Science ®Google Scholar
• Mcpherson T, Sherman V, Turner R. Imatinib-associated hyperpigmentation, a side effect that should be recognized. J Eur Acad Dermatol Venereol. 2009;23(1):82–83. doi:10.1111/j.1468-3083.2008.02706.x
   Web of Science ®Google Scholar
• Eljaaly K, Alireza KH, Alshehri SA-TJ, Al-Tawfiq JA. Hydroxychloroquine safety: a meta-analysis of randomized controlled trials. Travel Med Infect Dis. 2020;36:101812. doi:10.1016/j.tmaid.2020.101812
   Web of Science ®Google Scholar
• de Almeida VL, Lima IFP, Ziegelmann PK, Paranhos LR, de Matos FR. Impact of highly active antiretroviral therapy on the prevalence of oral lesions in HIV-positive patients: a systematic review and meta-analysis. Int J Oral Maxillofac Surg. 2017;46(11):1497–1504. doi:10.1016/j.ijom.2017.06.008
   PubMed Web of Science ®Google Scholar
• Hamza OJ, Matee MI, Simon EN, et al. Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health. 2006;6(1):12. doi:10.1186/1472-6831-6-12
   Google Scholar